Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Evidence Shows Ring Vaccination Strategy Effective In Limiting Ebola Outbreak In DRC 15/04/2019 David Branigan A preliminary analysis of the World Health Organization’s “ring vaccination” strategy against Ebola shows that vaccinating people who came into contact with Ebola patients is proving to be effective at preventing new cases and limiting the spread of the disease in the Democratic Republic of Congo (DRC). Image Credits: WHO. Continue reading -> Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Lack of Access To Antibiotics Is A Major Global Health Challenge 11/04/2019 Editorial team [CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> Posts navigation Older postsNewer posts